Quality of Life (QOL) Analysis of a Randomized Radiation Dose Escalation Non-Small Cell Lung Cancer (NSCLC) Study: Radiation Therapy Oncology Group (RTOG) Trial 0617

IMPORTANCE: A recent randomized radiation dose escalation trial in unresectable stage III NSCLC showed a lower survival in the high-dose arm (74Gy vs. 60Gy) with concurrent chemotherapy. Quality of life (QOL), an important secondary endpoint, is presented here. OBJECTIVE: The primary QOL hypothesis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Movsas, Benjamin, Hu, Chen, Sloan, Jeffrey, Bradley, Jeffrey, Komaki, Ritsuko, Masters, Gregory, Kavadi, Vivek, Narayan, Samir, Michalski, Jeff, Johnson, Douglas W., Koprowski, Christopher, Curran, Walter J., Garces, Yolanda I., Gaur, Rakesh, Wynn, Raymond B., Schallenkamp, John, Gelblum, Daphna Y., MacRae, Robert M, Paulus, Rebecca, Choy, Hak
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786463/
https://ncbi.nlm.nih.gov/pubmed/26606200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.3969
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars